Cargando…

Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing

INTRODUCTION: Vancomycin powder (VP) is an antibiotic first introduced in pediatric spinal surgery to prevent surgical site infections (SSI). Recently its topical application was expanded to total hip and knee arthroplasty (THA, TKA) and anterior cruciate ligament reconstruction (ACLR). Toxicity to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Benjamin, Wassilew, Georgi, von Eisenhart-Rothe, Rüdiger, Brodt, Steffen, Matziolis, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374468/
https://www.ncbi.nlm.nih.gov/pubmed/36538161
http://dx.doi.org/10.1007/s00402-022-04721-w
_version_ 1785078782635278336
author Jacob, Benjamin
Wassilew, Georgi
von Eisenhart-Rothe, Rüdiger
Brodt, Steffen
Matziolis, Georg
author_facet Jacob, Benjamin
Wassilew, Georgi
von Eisenhart-Rothe, Rüdiger
Brodt, Steffen
Matziolis, Georg
author_sort Jacob, Benjamin
collection PubMed
description INTRODUCTION: Vancomycin powder (VP) is an antibiotic first introduced in pediatric spinal surgery to prevent surgical site infections (SSI). Recently its topical application was expanded to total hip and knee arthroplasty (THA, TKA) and anterior cruciate ligament reconstruction (ACLR). Toxicity to cartilage is the subject of current research. The aim of this study was to prove the hypothesis that topical application of VP in TKA does not result in a degeneration of patella cartilage. We propagate that the conversion rate for secondary patella resurfacing is not influenced by its use. MATERIALS AND METHODS: Between 2014 and 2021, 4292 joints were included in this monocentric retrospective cohort study. All patients underwent TKA without primary patella resurfacing. After a change of the procedure in the hospital, one group (VPG) was administered VP intraoperatively. The other group (nVPG) received no VP during surgery (nVPG). The remaining perioperative procedure was constant over the investigation period. Conversion rates for secondary patella resurfacing for both groups were determined without making distinctions in the indication. A second cohort was composed of patients presenting for follow-up examination 12 months after TKA and included 210 joints. Retrospective radiographic evaluations were performed preoperatively, before discharge and at follow-up examination. Patella axial radiographs were analyzed for patella tracking (lateral patellar tilt, patellar displacement) and patella degeneration (Sperner classification, patellofemoral joint space). RESULTS: There was no significant difference in the conversion rate for secondary patella resurfacing (4.24% VPG, 4.97% nVPG). Patella tracking and patella degeneration did not differ significantly between both groups. CONCLUSIONS: The topical application of VP does not influence the conversion rate for secondary patella resurfacing. Moreover, it does not result in a degeneration of patella cartilage in TK. LEVEL OF EVIDENCE: Retrospective case series, Level III.
format Online
Article
Text
id pubmed-10374468
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103744682023-07-29 Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing Jacob, Benjamin Wassilew, Georgi von Eisenhart-Rothe, Rüdiger Brodt, Steffen Matziolis, Georg Arch Orthop Trauma Surg Knee Arthroplasty INTRODUCTION: Vancomycin powder (VP) is an antibiotic first introduced in pediatric spinal surgery to prevent surgical site infections (SSI). Recently its topical application was expanded to total hip and knee arthroplasty (THA, TKA) and anterior cruciate ligament reconstruction (ACLR). Toxicity to cartilage is the subject of current research. The aim of this study was to prove the hypothesis that topical application of VP in TKA does not result in a degeneration of patella cartilage. We propagate that the conversion rate for secondary patella resurfacing is not influenced by its use. MATERIALS AND METHODS: Between 2014 and 2021, 4292 joints were included in this monocentric retrospective cohort study. All patients underwent TKA without primary patella resurfacing. After a change of the procedure in the hospital, one group (VPG) was administered VP intraoperatively. The other group (nVPG) received no VP during surgery (nVPG). The remaining perioperative procedure was constant over the investigation period. Conversion rates for secondary patella resurfacing for both groups were determined without making distinctions in the indication. A second cohort was composed of patients presenting for follow-up examination 12 months after TKA and included 210 joints. Retrospective radiographic evaluations were performed preoperatively, before discharge and at follow-up examination. Patella axial radiographs were analyzed for patella tracking (lateral patellar tilt, patellar displacement) and patella degeneration (Sperner classification, patellofemoral joint space). RESULTS: There was no significant difference in the conversion rate for secondary patella resurfacing (4.24% VPG, 4.97% nVPG). Patella tracking and patella degeneration did not differ significantly between both groups. CONCLUSIONS: The topical application of VP does not influence the conversion rate for secondary patella resurfacing. Moreover, it does not result in a degeneration of patella cartilage in TK. LEVEL OF EVIDENCE: Retrospective case series, Level III. Springer Berlin Heidelberg 2022-12-20 2023 /pmc/articles/PMC10374468/ /pubmed/36538161 http://dx.doi.org/10.1007/s00402-022-04721-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Knee Arthroplasty
Jacob, Benjamin
Wassilew, Georgi
von Eisenhart-Rothe, Rüdiger
Brodt, Steffen
Matziolis, Georg
Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
title Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
title_full Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
title_fullStr Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
title_full_unstemmed Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
title_short Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
title_sort topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
topic Knee Arthroplasty
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374468/
https://www.ncbi.nlm.nih.gov/pubmed/36538161
http://dx.doi.org/10.1007/s00402-022-04721-w
work_keys_str_mv AT jacobbenjamin topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing
AT wassilewgeorgi topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing
AT voneisenhartrotherudiger topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing
AT brodtsteffen topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing
AT matziolisgeorg topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing